PPM1K and obesity disorder: Thus, increased levels of BCAA in plasma from subjects with obesity are likely to be the result of reduced expression of BCAT [50,57] or decreased BCKD activity via either increased expression of BCKDK [48,50,58,59] or suppression of PPM1K [54,60,61,62].